Heart failure is a leading cause of cardiovascular mortality and morbidity. It 
has been shown that inflammatory markers may play a role in the pathogenesis of 
heart failure. Therefore, inflammatory markers and anticytokine therapy in heart 
failure have become the attractive subjects in the literature. There are new 
studies regarding this issue in the literature. In this article, we reviewed 
inflammatory markers in heart failure and their prognostic significance based on 
the literature data.